Connect with us
Financial Press


The Wall Street Journal: Drug maker Teva’s U.S. unit indicted on price-fixing charges

The Wall Street Journal


Brent Kendall and

Jared S. Hopkins

Pharmaceutical giant is latest to be indicted in long-running investigation into generic-drug industry

Teva Pharmaceutical workers pack drugs in a clean room at the company’s manufacturing plant in Jerusalem.

Getty Images

WASHINGTON — The U.S. business of Teva Pharmaceutical Industries Ltd.

has been indicted on charges the drugmaker fixed prices on generic drugs, according to a person familiar with the matter.

The Justice Department is expected to announce the charges imminently, the person said.


Written By

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Articles


FA Center Published: Sept. 23, 2020 at 12:29 p.m. ET To understand why small-caps stumble at year-end, follow the Wall Street (bonus) money Getty...


The Fed Published: Sept. 23, 2020 at 12:21 p.m. ET Boston Fed president concerned about second wave of COVID-19 Boston Fed President Eric Rosengren...


Well, this is unfortunate… The story you requested could not be found. To find what you’re looking for, try one of these options. MarketWatch...


While trying to buy a house this summer, I assumed our real estate options were limited to homes that were officially for sale. Well,...